Pricing and launch strategy
Pricing strategy and launch planning across markets, from early price potential to launch execution.
Independent advisory · Life sciences
Pricing and Market Access Strategy
Hardenberg Advisory works with pharmaceutical and biotechnology companies on strategic pricing and market access, with a focus on the interplay between value and access.
Get in touch
Services
Strategic value communication
Shaping the value story and evidence narrative that payers and HTA bodies respond to, from early value proposition to launch-ready communication.
Negotiation strategy
Negotiation strategy and preparation for payer and HTA processes across European markets, with particular depth in the Netherlands (ZIN, VWS).
About
About
Dr Maarten Hardenberg
Around a decade of experience in life sciences, with over five years focused on strategic market access and pricing. I work on value, access, price and negotiation strategy, and health policy, for pharmaceutical and biotechnology companies across EU/UK, US and international markets, spanning therapy areas and asset types.
PhD in Chemistry, University of Cambridge · Author of publications across academia, healthcare policy and HEOR · Director, Medicine Access Channel.
Contact
maarten@hardenbergadvisory.com
Based in Cambridge, UK · Working across Europe · LinkedIn